These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Comparison of 3 Different Prothrombin Complex Concentrate Regimens for Emergent Warfarin Reversal: PCCWaR Study. Dietrich SK; Rowe S; Cocchio CA; Harmon AJ; Nerenberg SF; Blankenship PS Ann Pharmacother; 2021 Aug; 55(8):980-987. PubMed ID: 33305592 [TBL] [Abstract][Full Text] [Related]
9. Modified version of the American College of Cardiology's recommendation for low-dose prothrombin complex concentrate is effective for warfarin reversal. Gilbert BW; Morton L; Huffman JB; Roemer K; Potter A; Cassidy CD; Vasquez DG Am J Emerg Med; 2020 Apr; 38(4):806-809. PubMed ID: 31864879 [TBL] [Abstract][Full Text] [Related]
11. Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding. Stewart WS; Pettit H Am J Emerg Med; 2013 Aug; 31(8):1251-4. PubMed ID: 23763937 [TBL] [Abstract][Full Text] [Related]
12. Fixed-dose prothrombin complex concentrate for emergent warfarin reversal among patients with intracranial hemorrhage. Dietrich SK; Mixon MA; Rech MA Am J Emerg Med; 2021 Nov; 49():326-330. PubMed ID: 34224954 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal in Patients with Intracranial Hemorrhage. Scott R; Kersten B; Basior J; Nadler M J Emerg Med; 2018 Jun; 54(6):861-866. PubMed ID: 29510892 [TBL] [Abstract][Full Text] [Related]
14. Fixed- versus variable-dose prothrombin complex concentrate protocol for vitamin K antagonist reversal. Bizzell AC; Mousavi MK; Yin E Int J Hematol; 2021 Sep; 114(3):334-341. PubMed ID: 34191234 [TBL] [Abstract][Full Text] [Related]